Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Kappa Bioscience AS

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12 (consolidated)
Turnover 27,750 Less Arrow 23,269 More Arrow 28,171
Financial expenses 2,113 More Arrow 4,406 Less Arrow 1,581
Earnings before taxes 6,394 More Arrow 6,915 More Arrow 8,247
Total assets 44,743 Less Arrow 35,922 Less Arrow 27,535
Current assets 20,402 More Arrow 25,776 Less Arrow 18,511
Current liabilities 13,837 Less Arrow 9,145 Less Arrow 8,562
Equity capital 24,138 Less Arrow 23,081 Less Arrow 18,170
- share capital 144 More Arrow 153 Less Arrow 145

Financial ratios

Fiscal year 2022/12 2021/12 2020/12 (consolidated)
Solvency 53.9% More Arrow 64.3% More Arrow 66.0%
Turnover per employee
Profit as a percentage of turnover 23.0% More Arrow 29.7% Less Arrow 29.3%
Return on assets (ROA) 19.0% More Arrow 31.5% More Arrow 35.7%
Current ratio 147.4% More Arrow 281.9% Less Arrow 216.2%
Return on equity (ROE) 26.5% More Arrow 30.0% More Arrow 45.4%
Change turnover 5,703 Less Arrow -6,433 More Arrow 8,867
Change turnover % 26% 46%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.